Use of probiotics in the treatment and/or prevention of atopic dermatitis
AssigneesBionou Research, S.L., Biopolis, S.L.
InventorsVicente Manuel Navarro López, Ana Adela Ramírez Boscá, José Manuel Pérez Orquín, Daniel Ramón Vidal, Salvador Genovés Marténez, María Empar Chenoll Cuadros, Francisco Manuel Codoñer Cortés
Life of this patent
Estimating the term…
Abstract
The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
Claims1
A probiotic composition comprising Bifidobacterium animalis subsp. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, wherein B. lactis is B. lactis CECT 8145, B. longum is B. longum CECT 7347 and L. casei is L. casei CECT 9104, wherein
- B. longum concentration is 35% with respect to the total concentration of microorganisms present in the composition;
- B. lactis concentration is 35% with respect to the total concentration of microorganisms, and L. casei concentration is 30% with respect to the total concentration of microorganisms;
- the total concentration of microorganisms of the strains B. lactis, L. casei and B. longum in the composition is from 107 cfu to 108 cfu, and
- the probiotic composition is a food selected from the group consisting of fruit or vegetable juices and infant formula.
Dependencies are inferred from the claim text.